In conclusion, NT-proBNP serves as a promising biomarker for assessing disease severity and cardiac involvement in stable COPD, warranting further exploration as part of a multidimensional assessment strategy that encompasses spirometry, exercise testing, and cardiovascular evaluation. This evidence concerns the gene NPPB and chronic obstructive pulmonary disease.